Improvement of host-immunity by adjuvant therapy with Juzen-Taiho-To for patients with brain tumors

Neurological Surgery

Volumn 31, Issue 4, 2003, Pages 401-409

  Miyagami, Mitsusuke ^a,b   Katayama, Yoichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NIHON UNIVERSITY   (Japan)

Author keywords

Brain tumor; Juzen taiho to; NK activity; T cell subset; Tumor necrosis factor alpha

Indexed keywords

BETA INTERFERON; CHINESE DRUG; CYTOKINE; INTERFERON; SHI QUAN DA BU TANG; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTOMA; BRAIN TUMOR; CANCER ADJUVANT THERAPY; CANCER IMMUNOTHERAPY; CHINESE MEDICINE; CLINICAL ARTICLE; GLIOBLASTOMA; GLIOMA; HUMAN; IMMUNE SYSTEM; MENINGIOMA; NATURAL KILLER CELL; NEURINOMA; T LYMPHOCYTE SUBPOPULATION; TRADITIONAL MEDICINE; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DRUGS, CHINESE HERBAL; FEMALE; GLIOMA; HUMANS; INTERFERON-BETA; KILLER CELLS, NATURAL; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; T-LYMPHOCYTE SUBSETS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037389604     PISSN: 03012603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Durelli LD, Poccardi G, Cavallo R: CD8 + high CD11b + low T cells (T suppressor-effectors) in multiple sclerosis cerebrospinal fluid are increased during high dose corticosteroid treatment. J Neuroimmunol 31: 221-228, 1991
2. Fine HA, Dear KBG, Loeffler JS, Black PM, Canellos GP: Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597, 1993
3. Haranaka K, Satomi N, Sakurai A, Haranaka R, Okada N, Kobayashi M: Antitumor activities and tumor necrosis factor producibility of traditional Chinese medicines and crude drugs. Cancer Immunol. Immunother 20: 15, 1985
4. Gane P, Fain O, Mansour I, Roquin H, Rouger P: Expression of CD11b (Leu15) antigen on CD3+, CD4+, CD8+, CD16 + peripheral lymphocytes. Estimation of CD3 + 8 + 11b + and CD3 + 4 - 8 - 11b + T-cell subsets using a single laser flow cytometer. Scand J Immunol 36: 395-404, 1992
5. Koide J, Engleman EG: Differences in surface phenotype and mechanism of action between alloantigen-specific CD8 + cytotoxic and suppressor T cell clones. J Immunol 144: 32-40, 1990
6. Landay A, Gartland GL, Clement LT: Characterization of a phenotypically distinct subpopulation of Leu-2 + cells that suppresses T cell proliferative responses. J Immunol 131: 2757, 1983
7. Lebeck LK, Kaizer H, Gebel HM: Characterization of peripheral blood CD8/11b cells in bone marrow transplant recipients. III. Subsets of CD8/11b cells differentially regulate immunoglobulin production. Bone Marrow Transplantation 9: 35-39, 1992
8. Takahashi H, Nakazawa S: Antitumor effect of Junzentaiho-to, a kampo medicine, for transplanted malignant glioma. Int J Immunotherapy 11: 65-69, 1995
9. Takakura K, Abe H, Tanaka R, Kitamura K, Miwa T, Takeuchi K, Yamamoto S, Kageyama N, Handa H, Mogami H: Effects of ACNU and radiotherapy on glioma. J Neurosurg 64: 53-57, 1986